drugset / Trial / NCT04772443

Evaluate the Efficacy and Safety of DWJ1506 and DWJ1507

NCT04772443 ↗

Phase 3 Unknown 280 enrolled Daewoong Pharmaceutical Co. LTD.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine the efficacy and safety of DWJ1506 and DWJ1507 in the patients with dyslipidemia.

Timeline

Start
2021-02
Primary completion
2022-12
Completion
2022-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator DWC202011 Unknown — —
Subject DWJ1506 Unknown — —
Subject DWJ1507 Unknown — —

Indications